Presentation Information
[P2-11]Case study of deviations from incurred sample reanalysis (ISR) and its improvements for bioanalysis of biopharmaceuticals
*Yuichi Yokoyama1, Yoshimi Inoue1, Masahito Ito1, Tetsuya Ohta1 (1. Safety Research Laboratories, Research Division, Tanabe Pharma Corporation)
Keywords:
Incurred Sample Reanalysis (ISR),Bioanalytical method validation,Toxicokinetics analysis
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in